he LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes. Academic Article 2020 uri icon

authors

  • Elisabet Cuyàs
  • Javier A. Menendez
  • Juan Gumuzio
  • Sara Verdura
  • Joan Brunet
  • Joaquim Bosch-Barrera
  • Begoña Martin-Castillo
  • Tomás Alarcón
  • ENCINAR HIDALGO, JOSÉ ANTONIO
  • Ángel G. Martin

publication date

  • 2020